High Tower Advisors, LLC Adamis Pharmaceuticals Corp Put Options Transaction History

High Tower Advisors, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2022 Feb 08, 2023	BUY	$0.14 - $0.22 $8 - $13	61 Added 7.83%	840 $0
Q3 2022 Nov 09, 2022	BUY	$0.24 - $0.54 $186 - $420	779 New	779 $4,000
Q4 2021 Feb 10, 2022	SELL	$0.57 - $1.23 $15,652 - $33,775	-27,460 Reduced 98.07%	540 $8,000
Q3 2021 Nov 12, 2021	BUY	$0.92 - $1.18 $25,760 - $33,040	28,000 New	28,000 $7,000

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.